Brind.

Financial Comparison of LabCorp and HCA Healthcare

1 report, 1 independent Updated Sep 21
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A comparison of LabCorp and HCA Healthcare found that HCA Healthcare has higher revenue and earnings than LabCorp. HCA Healthcare is trading at a lower price-to-earnings ratio than LabCorp, and it has increased its dividend for six consecutive years. Labcorp has a beta of 0.88, suggesting its stock price is 12% less volatile than the S&P 500, while HCA Healthcare has a beta of 1.1.

From dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The comparison highlights differences in valuation and risk profiles between the two companies. HCA Healthcare pays a dividend yield of 0.7% with a 10.4% payout ratio, while Labcorp offers a 0.9% yield with a 23.8% payout ratio. These metrics influence investor decisions regarding risk and return.

From dailypolitical.com

Who's involved

  • LabCorpClinical laboratory company whose valuation is being compared to HCA Healthcare

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped